NFKB1 and metabolic dysfunction-associated steatotic liver disease: A 12‐week administration of 1 g of hesperidin combined with lifestyle correction could improve NAFLD‐related risk indicators by preventing NF‐κB activation and reducing hs‐CRP and TNF‐α, compared to lifestyle correction alone in patients with NAFLD.